Polomar Health ServicesPMHS 34 5-Year Yield-on-Cost % is 0.00 as of Jul. 10, 2026. GuruFocus rates PMHS with a GF Score™ of 34/100 and a GF Value™ of $12.43 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 280 Healthcare Providers & Services companies, Polomar Health Services ranks worse than 357142.5% on this metric.
The historical rank and industry rank for Polomar Health Services's 5-Year Yield-on-Cost % or its related term are showing as below:
PMHS's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.945 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Polomar Health Services (OTCPK:PMHS) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Polomar Health Services 5-Year Yield-on-Cost % Related Terms
PMHS vs DHTI, RDGT, BLMH: 5-Year Yield-on-Cost % Comparison
For the Pharmaceutical Retailers subindustry, Polomar Health Services's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's 5-Year Yield-on-Cost % falls into.
Polomar Health Services 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Polomar Health Services (PMHS) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 10, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #999999 out of 280 companies in the Healthcare Providers & Services industry.
Is Polomar Health Services' 5-Year Yield-on-Cost % too high?
Polomar Health Services' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Polomar Health Services ranks #999999 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Polomar Health Services has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' 5-Year Yield-on-Cost % compare to DHTI and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #999999 out of 280 companies for 5-Year Yield-on-Cost %. This places Polomar Health Services in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.95, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.43, compared to a current price of $0.12 — trading 99.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Polomar Health Services' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polomar Health Services (PMHS) Overvalued in 2026?
Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued.
The current stock price of $0.12 is trading 99.1% below its estimated GF Value™ of $12.43.
GuruFocus considers Polomar Health Services to be Possible Value Trap.
Key valuation signals for PMHS:
5-Year Yield-on-Cost %: 0.00
GF Value™: $12.43 vs. price of $0.12 (99.1% below fair value)
No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
34GF Score
Get the complete analysis for PMHS
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 